Bezuclastinib

Nonadvanced systemic mastocytosis

Manufacturer: Cogent Biosciences
Regulatory submission: NDA submitted December 2025
Launch: Anticipated in the second half of 2026
Last updated: September 17, 2026

Section

Product information and disease description Product description Product information

Drug/Drug, drug/disease interactions

1 evidence topic · 1 source

Effects of Bezuclastinib on other drugs

No evidence found.